CN103420995B - 噁唑烷酮-烷胺基-呋喃酮型化合物及其制法和用途 - Google Patents
噁唑烷酮-烷胺基-呋喃酮型化合物及其制法和用途 Download PDFInfo
- Publication number
- CN103420995B CN103420995B CN201310403337.2A CN201310403337A CN103420995B CN 103420995 B CN103420995 B CN 103420995B CN 201310403337 A CN201310403337 A CN 201310403337A CN 103420995 B CN103420995 B CN 103420995B
- Authority
- CN
- China
- Prior art keywords
- phenyl
- oxazolidone
- base
- dmso
- furanones
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 20
- 230000002924 anti-infective effect Effects 0.000 claims abstract description 3
- -1 washing Substances 0.000 claims description 90
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 59
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 30
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 24
- 238000006243 chemical reaction Methods 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 16
- 239000003480 eluent Substances 0.000 claims description 14
- 230000000845 anti-microbial effect Effects 0.000 claims description 12
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 10
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 claims description 10
- 238000010898 silica gel chromatography Methods 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 8
- 229910052794 bromium Inorganic materials 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- AFCIMSXHQSIHQW-UHFFFAOYSA-N [O].[P] Chemical compound [O].[P] AFCIMSXHQSIHQW-UHFFFAOYSA-N 0.000 claims description 5
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 claims description 5
- 229940059936 lithium bromide Drugs 0.000 claims description 5
- 239000012044 organic layer Substances 0.000 claims description 5
- 150000003222 pyridines Chemical class 0.000 claims description 5
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 238000004440 column chromatography Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 239000001632 sodium acetate Substances 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 3
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000000967 suction filtration Methods 0.000 claims description 3
- 238000010792 warming Methods 0.000 claims description 3
- 229960005475 antiinfective agent Drugs 0.000 claims description 2
- 239000010410 layer Substances 0.000 claims description 2
- 239000010813 municipal solid waste Substances 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 5
- 241000588747 Klebsiella pneumoniae Species 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 201000007336 Cryptococcosis Diseases 0.000 abstract description 2
- 241000221204 Cryptococcus neoformans Species 0.000 abstract description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 abstract description 2
- 206010022678 Intestinal infections Diseases 0.000 abstract 1
- 206010035664 Pneumonia Diseases 0.000 abstract 1
- 208000033809 Suppuration Diseases 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- VIHAEDVKXSOUAT-UHFFFAOYSA-N but-2-en-4-olide Chemical class O=C1OCC=C1 VIHAEDVKXSOUAT-UHFFFAOYSA-N 0.000 description 161
- 238000005160 1H NMR spectroscopy Methods 0.000 description 72
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 72
- 241000894006 Bacteria Species 0.000 description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000013641 positive control Substances 0.000 description 5
- 0 *C(C(OC1)=O)=C1OCCNC[C@@](CN1c2ccc(*)c(*)c2)OC1=O Chemical compound *C(C(OC1)=O)=C1OCCNC[C@@](CN1c2ccc(*)c(*)c2)OC1=O 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 229960003328 benzoyl peroxide Drugs 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940056360 penicillin g Drugs 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- 238000001243 protein synthesis Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 101001108716 Homo sapiens Ribosome biogenesis protein NSA2 homolog Proteins 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 102100021459 Ribosome biogenesis protein NSA2 homolog Human genes 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 238000009510 drug design Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 229940124307 fluoroquinolone Drugs 0.000 description 2
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 2
- 235000011285 magnesium acetate Nutrition 0.000 description 2
- 239000011654 magnesium acetate Substances 0.000 description 2
- 229940069446 magnesium acetate Drugs 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 210000004708 ribosome subunit Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- PXASTGBSGPFLFJ-UHFFFAOYSA-N 3-pyridin-3-ylbenzoic acid Chemical compound OC(=O)C1=CC=CC(C=2C=NC=CC=2)=C1 PXASTGBSGPFLFJ-UHFFFAOYSA-N 0.000 description 1
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- ROEIYFUDFXFAJE-UHFFFAOYSA-N CCOc(cc(C)cc1)c1[O](C)CC Chemical compound CCOc(cc(C)cc1)c1[O](C)CC ROEIYFUDFXFAJE-UHFFFAOYSA-N 0.000 description 1
- CHBXCQHBCCLICW-UHFFFAOYSA-N Cc(cc1)ccc1OCc1ccccc1 Chemical compound Cc(cc1)ccc1OCc1ccccc1 CHBXCQHBCCLICW-UHFFFAOYSA-N 0.000 description 1
- ZBCATMYQYDCTIZ-UHFFFAOYSA-N Cc(cc1O)ccc1O Chemical compound Cc(cc1O)ccc1O ZBCATMYQYDCTIZ-UHFFFAOYSA-N 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 201000008225 Klebsiella pneumonia Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 206010035717 Pneumonia klebsiella Diseases 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 238000010266 Sephadex chromatography Methods 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000006229 amino acid addition Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 1
- 229960003644 aztreonam Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical class O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- XUWPJKDMEZSVTP-LTYMHZPRSA-N kalafungina Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1[C@@H](C)O[C@H]1[C@@H]2OC(=O)C1 XUWPJKDMEZSVTP-LTYMHZPRSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 238000003034 scaffold hopping Methods 0.000 description 1
- 231100000161 signs of toxicity Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310403337.2A CN103420995B (zh) | 2013-09-07 | 2013-09-07 | 噁唑烷酮-烷胺基-呋喃酮型化合物及其制法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310403337.2A CN103420995B (zh) | 2013-09-07 | 2013-09-07 | 噁唑烷酮-烷胺基-呋喃酮型化合物及其制法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103420995A CN103420995A (zh) | 2013-12-04 |
CN103420995B true CN103420995B (zh) | 2015-07-01 |
Family
ID=49646417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310403337.2A Active CN103420995B (zh) | 2013-09-07 | 2013-09-07 | 噁唑烷酮-烷胺基-呋喃酮型化合物及其制法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103420995B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111825509B (zh) * | 2019-04-23 | 2021-12-21 | 中国科学院大连化学物理研究所 | 一种手性3,4,4-三取代吡咯烷酮类化合物的催化不对称合成方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006043121A1 (en) * | 2004-10-20 | 2006-04-27 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
CN101001853A (zh) * | 2004-08-06 | 2007-07-18 | 法玛西雅厄普约翰有限责任公司 | 作为抗细菌剂的含羟吲哚的唑烷酮类 |
CN101027296A (zh) * | 2004-07-29 | 2007-08-29 | 菲尔诺国际公司 | 噁唑烷酮化合物和组合物以及其有关的方法 |
CN101220002A (zh) * | 2007-12-28 | 2008-07-16 | 天津药物研究院 | 作为抗菌剂的噁唑烷酮类化合物 |
CN101248067A (zh) * | 2005-06-27 | 2008-08-20 | 菲尔若国际公司 | 唑烷酮衍生物及其作为抗生素的用途 |
CN101434584A (zh) * | 2007-11-15 | 2009-05-20 | 中山大学 | 具有抗菌活性的手性噁唑烷酮类化合物 |
CN101883768A (zh) * | 2007-10-02 | 2010-11-10 | 财团法人乙卯研究所 | 具有7元杂环的噁唑烷酮衍生物 |
CN102131811A (zh) * | 2008-06-24 | 2011-07-20 | 财团法人乙卯研究所 | 具有稠合环的*唑烷酮衍生物 |
CN102190656A (zh) * | 2010-03-16 | 2011-09-21 | 山东轩竹医药科技有限公司 | 含有五元杂环的噁唑烷酮抗菌素 |
-
2013
- 2013-09-07 CN CN201310403337.2A patent/CN103420995B/zh active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101027296A (zh) * | 2004-07-29 | 2007-08-29 | 菲尔诺国际公司 | 噁唑烷酮化合物和组合物以及其有关的方法 |
CN101001853A (zh) * | 2004-08-06 | 2007-07-18 | 法玛西雅厄普约翰有限责任公司 | 作为抗细菌剂的含羟吲哚的唑烷酮类 |
WO2006043121A1 (en) * | 2004-10-20 | 2006-04-27 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
CN101248067A (zh) * | 2005-06-27 | 2008-08-20 | 菲尔若国际公司 | 唑烷酮衍生物及其作为抗生素的用途 |
CN101883768A (zh) * | 2007-10-02 | 2010-11-10 | 财团法人乙卯研究所 | 具有7元杂环的噁唑烷酮衍生物 |
CN101434584A (zh) * | 2007-11-15 | 2009-05-20 | 中山大学 | 具有抗菌活性的手性噁唑烷酮类化合物 |
CN101220002A (zh) * | 2007-12-28 | 2008-07-16 | 天津药物研究院 | 作为抗菌剂的噁唑烷酮类化合物 |
CN102131811A (zh) * | 2008-06-24 | 2011-07-20 | 财团法人乙卯研究所 | 具有稠合环的*唑烷酮衍生物 |
CN102190656A (zh) * | 2010-03-16 | 2011-09-21 | 山东轩竹医药科技有限公司 | 含有五元杂环的噁唑烷酮抗菌素 |
Non-Patent Citations (3)
Title |
---|
3-(吗啉吡啶基)-5-取代异噁唑类化合物的合成及抗菌活性研究;杜光剑等;《有机化学》;20091015;第29卷(第10期);1575-1571 * |
噁唑烷酮抗菌剂构效关系研究进展;秦文灵等;《中国药学杂志》;20100731;第45卷(第13期);第963页左栏1.5节 * |
噁唑烷酮类抗菌药物的合成;何飚等;《国外医药(抗生素分册)》;20090315;第30卷(第02期);82-88 * |
Also Published As
Publication number | Publication date |
---|---|
CN103420995A (zh) | 2013-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kalaria et al. | Ultrasound-assisted one-pot four-component synthesis of novel 2-amino-3-cyanopyridine derivatives bearing 5-imidazopyrazole scaffold and their biological broadcast | |
Kelley et al. | 3-Phenyl substituted 6, 7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents | |
Yu et al. | Fundamental structure–Activity relationships associated with a new structural class of respiratory syncytial virus inhibitor | |
CA2506772A1 (en) | Compositions useful as inhibitors of jak and other protein kinases | |
CN113354651B (zh) | 吡唑并[1,5-a]喹唑啉衍生物及其在药物制备中的用途 | |
El-Zahabi et al. | New thiobarbituric acid scaffold-based small molecules: Synthesis, cytotoxicity, 2D-QSAR, pharmacophore modelling and in-silico ADME screening | |
El Faydy et al. | Synthesis, Characterization and Biological Activity of Some Novel 5-((4-Alkyl piperazin-1-yl) methyl) quinolin-8-ol Derivatives | |
CN103420995B (zh) | 噁唑烷酮-烷胺基-呋喃酮型化合物及其制法和用途 | |
CN103450174B (zh) | 苯并吡喃酮-苯基-噁唑烷酮型化合物及其制法和用途 | |
CN103360382A (zh) | 喹唑啉衍生物及用途 | |
CN108929324A (zh) | 新型1,1-环丙基二酰胺衍生物的制备与应用 | |
CN102558172B (zh) | 5,8-二取代-1,6-二氮杂萘-7-羰酰胺类化合物及其二聚体化合物,其制备方法和用途 | |
CN103420996B (zh) | 苯并吡喃酮-胺甲基-噁唑烷酮类化合物及其制法和用途 | |
Arab et al. | New 7-piperazinylquinolones containing (benzo [d] imidazol-2-yl) methyl moiety as potent antibacterial agents | |
Nawrot et al. | N‐pyridinylbenzamides: an isosteric approach towards new antimycobacterial compounds | |
CN103483329B (zh) | 呋喃酮-芳基-噁唑烷酮型化合物及其制法和用途 | |
CN105294661B (zh) | 5‑氟尿嘧啶苯并咪唑类化合物及其制备方法和应用 | |
CN103450173B (zh) | 吡咯酮-苯基-噁唑烷酮型化合物及其制法和用途 | |
CN103121991A (zh) | 一种芳基羧酸类伊马替尼衍生物及其制备和用途 | |
Ejaz et al. | N‐([1, 1ʹ‐biaryl]‐4‐yl)‐1‐naphthamide‐based scaffolds synthesis, their cheminformatics analyses, and screening as bacterial biofilm inhibitor | |
Phillips et al. | Effects of varied substituents on the antibacterial activity of triazolylmethyl oxazolidinones | |
CN103420997B (zh) | 吡咯酮-胺甲基-噁唑烷酮型化合物及其制法和用途 | |
CN102690269B (zh) | 三氟甲基取代的喹啉或喹喔啉类化合物、其制备方法、包含该化合物的药物组合物及其用途 | |
CN103435600B (zh) | 烷基连接喹啉酮-呋喃酮型化合物及其制法和用途 | |
CN113045494B (zh) | 吡啶酮衍生物及其在制备预防和/或治疗结核分枝杆菌所引起的结核病的药物中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhao Wenhong Inventor before: Xiao Zhuping Inventor before: Lu Chunlei Inventor before: Man Zere |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171208 Address after: The green food of Wuhu Economic Development Zone in Anhui province Wuhu City Sanshan District 241000 Patentee after: Zhao Wenhong Address before: 416000 Hunan, Xiangxi Tujia and Miao Autonomous Prefecture, Jishou City People's road, No. 120 Patentee before: Jishou University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180612 Address after: 330114 No. 10, Xiong Jia village, Xinjian County, Nanchang, Jiangxi Patentee after: Liu Yanfang Address before: 241000 Anhui Wuhu Wuhu green food Economic Development Zone Patentee before: Zhao Wenhong |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181211 Address after: 230000 B-1512, west of Ganquan Road, Shushan District, Hefei, Anhui. Patentee after: Anhui Eagle Dragon Industrial Design Co., Ltd. Address before: 330114 No. 10, Xiong Jia village, Xinjian County, Nanchang, Jiangxi Patentee before: Liu Yanfang |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191203 Address after: 221300 Xinhua Village, official Town, Pizhou City, Jiangsu, Xuzhou Patentee after: PIZHOU CITY XIAOHE TECHNOLOGY DEVELOPMENT CO., LTD. Address before: Ganquan road Shushan District of Hefei City, Anhui Province, 230000 West hillock road to the South Wild Garden commercial office building room B-1512 Patentee before: Anhui Eagle Dragon Industrial Design Co., Ltd. |